FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897746394> ?p ?o ?g. }

• W2897746394 abstract "Objective: To assess the detection rate of chromosomal microarray (CMA) when utilized in patients with cerebral palsy (CP). Background: Several medical organizations, including the AAN[1], support the use of CMA in patients with neurodevelopmental disabilities such as intellectual disability (ID), developmental delay (DD), autism spectrum disorder (ASD), and multiple congenital anomalies (MCA). The AAN has also issued a practice parameter regarding the diagnostic assessment of patients with CP[2]. This parameter includes recommendations for neuroimaging, but states that metabolic/genetic causes that underlie or masquerade as CP are infrequent (less than 4%). This parameter was issued in 2004, prior to the onset of high-resolution CMA. Design/Methods: We retrospectively assessed our clinical laboratory database for patients with CP who underwent high-resolution CMA from September 1, 2010 through September 30, 2016. Testing indication (ICD-9/ICD-10 codes) included CP with or without additional features. Results: There were 69 out of 11,370 patients with CP (0.6%) in our database. Among those with CP, 48 had a normal result (69.6%), 12 had a variant of unknown significance (VOUS) result (17.4%), and 9 had a pathogenic result (13.0%). Two patients with pathogenic copy number variants (CNVs) had a 17p12 duplication consistent with Charcot-Marie-Tooth type 1A. Conclusions: The rate of patients with CP in our testing database is low (0.6% of total referrals), indicating that clinicians do not consider genetic conditions a common underlying etiology. However, the rate of pathogenic CNVs in this cohort (13%) is comparable to and in some cases higher than pathogenic detection rates reported in individuals with ID and other guideline-recommended indications for CMA. High-resolution CMA should be a recommendation for diagnostic testing in patients with CP. Study Supported by: Disclosure: Dr. Vanzo has received personal compensation for activities with Lineagen as an employee. Dr. Vanzo has stock and/or stock options with Lineagan. Dr. Vanzo has received research support from Lineagan. Dr. Harward has received personal compensation for activities with Lineagen. Dr. Harward holds stock and/or stock options in Lineagen, which sponsored research in which Dr. Harward was involoved as an investigator. Dr. Harward holds stock and/or stock options in Lineagen. Dr. Harward has received research support from Lineagen. Dr. Ho has received personal compensation for activities with Lineagen as an employee. Dr. Ho holds stock and/or stock options in Lineagen, an employee. Dr. Ho has received research support from Lineagen. Dr. Wassman has received personal compensation for activities with Lineagen as an employee. Dr. Wassman holds stock and/or stock options in Lineagen." @default.
• W2897746394 created "2018-10-26" @default.
• W2897746394 creator A5002509106 @default.
• W2897746394 creator A5018331289 @default.
• W2897746394 creator A5021150258 @default.
• W2897746394 creator A5074932553 @default.
• W2897746394 date "2017-04-18" @default.
• W2897746394 modified "2023-09-23" @default.
• W2897746394 title "Detection rate of chromosomal microarray genetic testing in patients with cerebral palsy (P4.152)" @default.
• W2897746394 hasPublicationYear "2017" @default.
• W2897746394 type Work @default.
• W2897746394 sameAs 2897746394 @default.
• W2897746394 citedByCount "0" @default.
• W2897746394 crossrefType "journal-article" @default.
• W2897746394 hasAuthorship W2897746394A5002509106 @default.
• W2897746394 hasAuthorship W2897746394A5018331289 @default.
• W2897746394 hasAuthorship W2897746394A5021150258 @default.
• W2897746394 hasAuthorship W2897746394A5074932553 @default.
• W2897746394 hasConcept C104317684 @default.
• W2897746394 hasConcept C118552586 @default.
• W2897746394 hasConcept C120821319 @default.
• W2897746394 hasConcept C126322002 @default.
• W2897746394 hasConcept C137627325 @default.
• W2897746394 hasConcept C141231307 @default.
• W2897746394 hasConcept C150194340 @default.
• W2897746394 hasConcept C167135981 @default.
• W2897746394 hasConcept C186836561 @default.
• W2897746394 hasConcept C187212893 @default.
• W2897746394 hasConcept C201903717 @default.
• W2897746394 hasConcept C205778803 @default.
• W2897746394 hasConcept C2778538070 @default.
• W2897746394 hasConcept C2779421357 @default.
• W2897746394 hasConcept C2780673598 @default.
• W2897746394 hasConcept C54355233 @default.
• W2897746394 hasConcept C551499885 @default.
• W2897746394 hasConcept C58693492 @default.
• W2897746394 hasConcept C71924100 @default.
• W2897746394 hasConcept C72563966 @default.
• W2897746394 hasConcept C7602840 @default.
• W2897746394 hasConcept C86803240 @default.
• W2897746394 hasConceptScore W2897746394C104317684 @default.
• W2897746394 hasConceptScore W2897746394C118552586 @default.
• W2897746394 hasConceptScore W2897746394C120821319 @default.
• W2897746394 hasConceptScore W2897746394C126322002 @default.
• W2897746394 hasConceptScore W2897746394C137627325 @default.
• W2897746394 hasConceptScore W2897746394C141231307 @default.
• W2897746394 hasConceptScore W2897746394C150194340 @default.
• W2897746394 hasConceptScore W2897746394C167135981 @default.
• W2897746394 hasConceptScore W2897746394C186836561 @default.
• W2897746394 hasConceptScore W2897746394C187212893 @default.
• W2897746394 hasConceptScore W2897746394C201903717 @default.
• W2897746394 hasConceptScore W2897746394C205778803 @default.
• W2897746394 hasConceptScore W2897746394C2778538070 @default.
• W2897746394 hasConceptScore W2897746394C2779421357 @default.
• W2897746394 hasConceptScore W2897746394C2780673598 @default.
• W2897746394 hasConceptScore W2897746394C54355233 @default.
• W2897746394 hasConceptScore W2897746394C551499885 @default.
• W2897746394 hasConceptScore W2897746394C58693492 @default.
• W2897746394 hasConceptScore W2897746394C71924100 @default.
• W2897746394 hasConceptScore W2897746394C72563966 @default.
• W2897746394 hasConceptScore W2897746394C7602840 @default.
• W2897746394 hasConceptScore W2897746394C86803240 @default.
• W2897746394 hasOpenAccess W2897746394 @default.
• W2897746394 hasRelatedWork W1418354795 @default.
• W2897746394 hasRelatedWork W1975312779 @default.
• W2897746394 hasRelatedWork W2314585107 @default.
• W2897746394 hasRelatedWork W2559000664 @default.
• W2897746394 hasRelatedWork W2587054333 @default.
• W2897746394 hasRelatedWork W2613256121 @default.
• W2897746394 hasRelatedWork W2613423912 @default.
• W2897746394 hasRelatedWork W2726514908 @default.
• W2897746394 hasRelatedWork W2793368043 @default.
• W2897746394 hasRelatedWork W2799607811 @default.
• W2897746394 hasRelatedWork W2809404595 @default.
• W2897746394 hasRelatedWork W2891524065 @default.
• W2897746394 hasRelatedWork W2947648285 @default.
• W2897746394 hasRelatedWork W3007098196 @default.
• W2897746394 hasRelatedWork W3089864083 @default.
• W2897746394 hasRelatedWork W3186495078 @default.
• W2897746394 hasRelatedWork W3207677519 @default.
• W2897746394 hasRelatedWork W3212280551 @default.
• W2897746394 hasRelatedWork W3213053427 @default.
• W2897746394 hasRelatedWork W2121733138 @default.
• W2897746394 hasVolume "88" @default.
• W2897746394 isParatext "false" @default.
• W2897746394 isRetracted "false" @default.
• W2897746394 magId "2897746394" @default.
• W2897746394 workType "article" @default.